查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611911

3D 列印製藥市場：按技術、劑型、應用、最終用戶分類 - 全球預測 2025-2030

3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年3D列印藥品市值為2.9272億美元，預計到2024年將達到3.3122億美元，複合年成長率為14.26%，到2030年將達到7.4429億美元。

3D列印藥物市場是製藥業的一個創新領域，旨在透過利用賦形劑製造技術來創造個人化藥物，從而徹底改變藥物製造。對3D列印藥品的需求源於對患者特定藥物日益成長的需求，這些藥物的劑量、劑型和成分可以客製化，以有效滿足個人健康需求。 3D列印藥物的應用範圍包括慢性病管理、老年護理、小兒科等。最終用途包括醫院、製藥公司和研究機構，所有這些都需要高效、經濟高效和客製化的藥品製造能力。

主要市場統計
基準年[2023] 2.9272億美元
預計年份 [2024] 33122萬美元
預測年份 [2030] 74429萬美元
複合年成長率（%） 14.26%

市場的關鍵成長要素包括技術進步、慢性病的增加以及衛生當局對個人化醫療的監管支持。減少藥物浪費和提高患者依從性的潛力正在進一步推動該市場的擴張。透過利用與醫療保健提供者的夥伴關係關係並投資於研發，有機會使用 3D 列印技術來開發有效且易於製造的新型藥物配方。然而，高昂的初始成本、技術限制和嚴格的監管要求等挑戰可能會阻礙市場成長。此外，醫療保健提供者缺乏廣泛的認可和接受也是一個額外的障礙。

具有巨大潛力的創新研發領域包括開發用於藥物列印的生物相容性和生物分解性材料、提高印表機的速度和精度以及透過3D列印實現劑型多樣化。透過專注於這些創新並培養策略聯盟來加強我們的市場影響力和基礎設施，可以實現業務成長。市場的本質是動態的，其特點是快速的技術創新和對精準醫療的日益重視。透過建立強大的分銷網路並參與持續的相關人員教育計劃，公司可以倡導放寬限制並將 3D 列印藥物納入主流醫療保健實踐。

市場動態：揭示快速發展的 3D 列印製藥市場的關鍵市場洞察

供需的動態交互作用正在改變 3D 列印製藥市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 對速溶藥物的需求迅速成長
    • 擴大個人化藥物的採用和生產組合藥物
    • 擴大3D列印技術在抗癌藥物生產的應用
  • 市場限制因素
    • 與 3D 列印藥品製造相關的材料限制
  • 市場機會
    • 3D列印技術持續技術發展
    • 3D列印藥物製造的重大投資
  • 市場挑戰
    • 3D 列印藥品製造的複雜性

波特五力：駕馭 3D 列印製藥市場的策略工具

波特的五力架構是了解 3D 列印藥品市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 3D 列印製藥市場的外部影響

外部宏觀環境因素在塑造 3D 列印藥品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解3D列印醫藥市場競爭狀況

對 3D 列印藥品市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 3D 列印藥品市場供應商的績效評估

FPNV 定位矩陣是評估 3D 列印藥品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 3D 列印藥品市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 3D 列印藥品市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對速效藥物的需求迅速增加
      • 擴大個人化藥物的採用和複雜藥物的生產
      • 廣泛利用3D列印技術製造癌症治療藥物
    • 抑制因素
      • 與 3D 列印藥品製造相關的材料限制
    • 機會
      • 3D列印技術持續技術發展
      • 大量投資生產 3D 列印藥品
    • 任務
      • 3D 列印藥品製造的複雜性
  • 市場區隔分析
    • 技術：直寫技術提供個人化、有效的劑量解決方案
    • 劑型：可採用膠囊形式的 3D 列印藥物
    • 應用：擴大在神經系統藥物製造的應用
    • 最終用戶：3D列印藥品在診所和醫院的滲透率較高
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 3D 列印藥品市場：依技術分類

  • 直接寫入
  • 熔融沈積法
  • 噴墨印刷
  • 粉紅床印刷
  • 立體光刻技術
  • 拉鍊劑量

第7章依劑型分類的3D列印藥品市場

  • 膠囊
  • 奈米粒子
  • 錠劑

第8章 3D列印醫藥市場：依應用分類

  • 牙科
  • 神經病學
  • 整形外科

第 9 章 3D 列印製藥市場：依最終用戶分類

  • 診所和醫院
  • 研究室
  • 專科診所

第10章美洲3D列印藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區3D列印醫藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲3D列印藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Triastek 和 BioNTech 合作開發口服 3D 列印 RNA 療法，目標是超過 12 億美元的里程碑付款
    • Carsinotech籌集420萬英鎊進軍美國，推動個人化腫瘤藥物開發的3D列印微腫瘤技術
    • CurifyLabs 推出個人化醫療 3D 列印解決方案
    • Cellink 和 Carcinotech 合作透過 3D 生物列印轉變癌症藥物開發
    • Triastek 的 3D 列印藥物治療潰瘍性大腸炎獲得 FDA IND核准
  • 戰略分析和建議

公司名單

  • 3D Systems, Inc.
  • 3DR HOLDINGS
  • Anatomics Pty Ltd
  • Aprecia Pharmaceuticals, LLC
  • AstraZeneca plc
  • BioDuro, LLC
  • Biomedical Modeling Inc.
  • Cycle Pharmaceuticals
  • Cyfuse Biomedical KK
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • GlaxoSmithKline Plc
  • Materialise NV
  • Merck KGaA
  • Organovo Holdings Inc.
  • Proto Labs Inc.
  • Renishaw PLC
  • Rokit Healthcare Inc.
  • Siemens AG
  • Stratasys Ltd.
  • Triastek, Inc.
  • TVASTA
  • Yissum
  • Zortrax SA
Product Code: MRR-431C35F6C179

The 3D Printed Drugs Market was valued at USD 292.72 million in 2023, expected to reach USD 331.22 million in 2024, and is projected to grow at a CAGR of 14.26%, to USD 744.29 million by 2030.

The 3D printed drugs market is an innovative segment in the pharmaceutical industry that aims to revolutionize drug manufacturing by utilizing additive manufacturing techniques to create personalized medication. The need for 3D printed drugs arises from the growing demand for patient-specific medication that can adjust dosages, forms, and compositions to meet individual health requirements effectively. Applications of 3D printed drugs span across chronic disease management, elder care, and pediatrics, where tailored dosages are crucial. The end-use scope includes hospitals, pharmaceutical companies, and research institutions, all seeking efficient, cost-effective, and customized drug production capabilities.

KEY MARKET STATISTICS
Base Year [2023] USD 292.72 million
Estimated Year [2024] USD 331.22 million
Forecast Year [2030] USD 744.29 million
CAGR (%) 14.26%

Key growth factors in this market include technological advancements, the increasing incidence of chronic diseases, and regulatory support from health authorities for personalized medicine. The potential to reduce drug wastage and enhance patient compliance further augments this market's expansion. Opportunities lie in leveraging partnerships with healthcare providers and investing in R&D to develop novel drug formulations that are both efficacious and easy to produce using 3D printing technology. However, challenges such as high initial costs, technical limitations, and stringent regulatory requirements could impede market growth. Additionally, the lack of widespread awareness and acceptance among healthcare providers poses further hurdles.

Innovative research areas with significant potential include developing biocompatible and biodegradable materials for drug printing, enhancing printer speed and precision, and creating a wider array of 3D printed dosage forms. Business growth can be realized by focusing on these technological innovations and fostering strategic alliances that bolster market presence and infrastructure. The nature of the market is dynamic, characterized by rapid technological changes and a growing emphasis on precision medicine. Companies might benefit from developing robust distribution networks and engaging in continuous education initiatives for stakeholders to mitigate limitations and advocate for the integration of 3D printed drugs in mainstream healthcare practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Printed Drugs Market

The 3D Printed Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in demand for instantaneous soluble drugs
    • Growing adoption of personalized drugs and the production of combination medicine
    • Extensive use of 3D printed technology for manufacturing cancer drugs
  • Market Restraints
    • Material limitations associated with manufacturing of 3D printed drugs
  • Market Opportunities
    • Constant technological developments in 3D printing technique
    • Significant investments for manufacturing of 3D printed pharmaceuticals
  • Market Challenges
    • Complexities in manufacturing of 3D printed drugs

Porter's Five Forces: A Strategic Tool for Navigating the 3D Printed Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Printed Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Printed Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Printed Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Printed Drugs Market

A detailed market share analysis in the 3D Printed Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Printed Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Printed Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Printed Drugs Market

A strategic analysis of the 3D Printed Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
  • Based on Dose Form, market is studied across Capsule, Nanoparticles, and Tablet.
  • Based on Application, market is studied across Dental, Neurology, and Orthopedic.
  • Based on End-User, market is studied across Clinics & Hospitals, Research Laboratories, and Speciality Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in demand for instantaneous soluble drugs
      • 5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
      • 5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant technological developments in 3D printing technique
      • 5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in manufacturing of 3D printed drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
    • 5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
    • 5.2.3. Application: Proliferating use for manufacturing of neurology drugs
    • 5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 3D Printed Drugs Market, by Technology

  • 6.1. Introduction
  • 6.2. Direct-Write
  • 6.3. Fused Deposition Modelling
  • 6.4. Inkjet Printing
  • 6.5. Powder Bed Printing
  • 6.6. Stereolithography
  • 6.7. Zip Dose

7. 3D Printed Drugs Market, by Dose Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Nanoparticles
  • 7.4. Tablet

8. 3D Printed Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Dental
  • 8.3. Neurology
  • 8.4. Orthopedic

9. 3D Printed Drugs Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics & Hospitals
  • 9.3. Research Laboratories
  • 9.4. Speciality Clinics

10. Americas 3D Printed Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific 3D Printed Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa 3D Printed Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Triastek and BioNTech partner to develop 3D printed RNA therapeutics for oral delivery, aiming for over USD 1.2 billion in milestone payments
    • 13.3.2. Carcinotech raises GBP 4.2 million for US expansion, enhancing 3D-printed micro-tumour tech for personalized oncology drug development
    • 13.3.3. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
    • 13.3.4. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
    • 13.3.5. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Systems, Inc.
  • 2. 3DR HOLDINGS
  • 3. Anatomics Pty Ltd
  • 4. Aprecia Pharmaceuticals, LLC
  • 5. AstraZeneca plc
  • 6. BioDuro, LLC
  • 7. Biomedical Modeling Inc.
  • 8. Cycle Pharmaceuticals
  • 9. Cyfuse Biomedical K.K.
  • 10. EnvisionTEC GmbH
  • 11. FabRx Ltd.
  • 12. General Electric Company
  • 13. GlaxoSmithKline Plc
  • 14. Materialise NV
  • 15. Merck KGaA
  • 16. Organovo Holdings Inc.
  • 17. Proto Labs Inc.
  • 18. Renishaw PLC
  • 19. Rokit Healthcare Inc.
  • 20. Siemens AG
  • 21. Stratasys Ltd.
  • 22. Triastek, Inc.
  • 23. TVASTA
  • 24. Yissum
  • 25. Zortrax S.A.

LIST OF FIGURES

  • FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. 3D PRINTED DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023